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Conclusion: A reasonable high correlation in response during 
chemoradiation between the primary lung tumour and lymph 
nodes was observed, but a large inter- and intra-patient 
variability was observed. These preliminary results suggest 
that treatment plan modification based on metabolic 
treatment response should be tailored to individual lesions.  
[1] van Elmpt et al., J Nucl Med. 2012 
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Purpose or Objective: Apparent diffusion coefficient (ADC), 
derived from diffusion-weighted MRI (DW-MRI) is a promising 
assessment method during radiotherapy treatment, but 
geometric distortion is its main disadvantage. This study 
investigates the use of the reversed gradient method (RGM) 
in DW-MRI for reduction in geometric distortion and 
vascularization from dynamic studies of MRI (DCEMRI), as a 
surrogate measure of oxygenation in H&N cancer. 
 
Material and Methods: We studied the variation of ADC of 
three oropharynx cancer patients included in ARTFIBIO 
project. Three functional imaging scans were performed 
before treatment: PET/CT, DWMRI and DCEMRI; two MRI 
scans during the treatment; and three months after the 
treatment, the initial studies were repeated. Geometric 
distortion of DWMRI was corrected using RGM (SPM8 software, 
HySCO options). DCEMRI analyses were performed using 
Dynamika® v4.0 (www.imageanalysis.org.uk). Registration 
and mutual information were calculated with ARTFIBio tools. 
Mutual information of T2-weighted and DW-MRI was 
calculated for corrected and uncorrected DW-MRI. Initial 
Rate Enhancement (IRE) from DCEMRI was selected as a 
possible biomarker associated with vascularization / hypoxia. 
 
Results: Table shows the increment in mutual information for 
the initial ADC maps of the three patients when correcting by 
RGM. For two first patients, a large increment is observed 
and for the third patient, although the mutual information 
didn’t show it, the visual appreciation is quite relevant. In 
Figure A, the visual improvement of corrected images can be 
appreciated. 
We also measured the variation of ADC during the treatment 
(Figure B), and three months later. The colour in the dots 
shows the initial IRE values in arbitrary units. As the dose is 
delivered, best-vascularized dots move to the upper part of 
the cloud corresponding to different instants along the 
treatment. 
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shift 
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by 
Reversed 
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Anterior 
shift 
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shift 
Corrected 
by 
Reversed 
gradient 
#1 0.563 0.656 0.872 0.655 0.325 0.900 
#2 0.308 0.454 0.775 0.381 0.445 0.730 
#3 0.439 0.548 0.548 0.545 0.522 0.567 
 
Conclusion: RGM improves registration and provides accurate 
ADC in tumors. We suggest correction of distortion with the 
RGM should form part of an imaging method for treatment 
response using ADC to assess tumor response or tumor cell 
density variation with treatment in cancer patients, and 
DCEMRI can be useful for characterizing hypoxia in H&N 
cancers. Supported by ISCIII Grant DTS14/00188 
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